Seminars in Hematology
Volume 42, Issue 3 , Pages 119-121 , July 2005

Immune Hemolytic Anemia—A Primer

References 

  1. Dacie JV . In: The Haemolytic Anaemias, vol 1. Part 1, The Hereditary Haemolytic Anaemias . (ed 3). New York, NY: Churchill Livingstone; 1985;
  2. Petz LD , Garratty G . Acquired Immune Hemolytic Anemias . New York, NY: Churchill Livingstone; 1980;
  3. Dacie JV . Auto-immune haemolytic anaemia (AIHA): Warm-antibody syndromes, I: “Idiopathic” types: History and clinical features . In: The Haemolytic Anaemias vol 3, The Auto-Immune Haemolytic Anaemias . (ed 3). New York, NY: Churchill Livingstone; 1992;p. 6–53
  4. Petz LD , Garratty G . In: Immune Hemolytic Anemias . (ed 2). Philadelphia, PA: Churchill Livingstone; 2004;
  5. Semple JW , Freedman J . Autoimmune pathogenesis and autoimmune hemolytic anemia . Semin Hematol . 2005;42:122–130
  6. Arndt PA , Garratty G . The changing spectrum of drug-induced immune hemolytic anemia . Semin Hematol . 2005;42:137–144
  7. King KE , Ness PM . Treatment of autoimmune hemolytic anemia . Semin Hematol . 2005;42:131–136
  8. Kaplan HS , Garratty G . Predictive value of direct antiglobulin test results . Diagn Med . 1985;8:29–32
  9. Garratty G . Immune hemolytic anemia associated with negative routine serology . Semin Hematol . 2005;42:156–164
  10. Linden JV , Kaplan HS . Transfusion errors (Causes and effects) . Trans Med Rev . 1994;8:169–183
  11. Williamson L , Cohen H , Love E , Jones H , Todd A , Soldan K , et al.   The serious hazards of transfusion (SHOT) initiative; the UK approach to haemovigilance . Vox Sang . 2000;78:291–295
  12. Taswell HF , Pineda AA , Moore SB . Hemolytic transfusion reactions (Frequency and clinical and laboratory aspects) . In:  Bell CA editors. A Seminar on Immune-Mediated Cell Destruction . Washington DC: American Association of Blood Banks; 1981;p. 71
  13. Davenport RD . Pathophysiology of hemolytic transfusion reactions . Semin Hematol . 2005;42:165–168
  14. Vamvakas EC , Pineda AA , Reisner R , Santrach PJ , Moore SB . The differentiation of delayed hemolytic and delayed serologic transfusion reactions (Incidence and predictors of hemolysis) . Transfusion . 1995;35:26–32
  15. Pineda AA , Vamvakas EC , Gorden LD , Winters JL , Moore SB . Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions . Transfusion . 1999;39:1097–1103
  16. Rosse WF , Gallagher D , Kinney TR , Castro O , Dosik H , Moohr J , et al.   Transfusion and alloimmunization in sickle cell disease . Blood . 1990;76:1431–1437
  17. Garratty G . Severe reactions associated with transfusion of patients with sickle cell disease . Transfusion . 1997;37:357–361
  18. Vichinsky EP , Earles A , Johnson RA , Hoag MS , Williams A , Lubin B , et al.   Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood . N Engl J Med . 1990;322:1617–1621
  19. Petz LD , Calhoun L , Shulman IA , Johnson C , Herron RM . The sickle cell hemolytic transfusion reaction syndrome . Transfusion . 1997;37:382–392
  20. King KE , Shirey RS , Lankiewicz MW , et al.   Delayed hemolytic transfusion reactions in sickle cell disease (Simultaneous destruction of recipients’ red cells) . Transfusion . 1997;37:376–381
  21. Moise KJ . Red cell alloimmunization in pregnancy . Semin Hematol . 2005;42:169–178

PII: S0037-1963(05)00054-5

doi: 10.1053/j.seminhematol.2005.04.001

Seminars in Hematology
Volume 42, Issue 3 , Pages 119-121 , July 2005

Article Tools

* Image Usage & Resolution